Cosmo Pharmaceuticals N.V. (CMOPF)

Market Cap	2.38B +106.2%
Revenue (ttm)	214.06M -1.7%
Net Income	70.45M +1.7%
EPS	4.31 +0.1%
Shares Out	n/a
PE Ratio	33.85
Forward PE	430.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	404
Average Volume	453
Open	145.90
Previous Close	155.00
Day's Range	145.90 - 155.00
52-Week Range	55.00 - 169.90
Beta	1.46
RSI	54.48
Earnings Date	Mar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1997
• Employees: 332
• Stock Exchange: OTCMKTS
• Ticker Symbol: CMOPF

Financial Performance

Financial numbers in EUR